Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Methylprednisolone hemisuccinate
Drug ID BADD_D01435
Description A water-soluble ester of methylprednisolone used for cardiac, allergic, and hypoxic emergencies.
Indications and Usage Adjunctive therapy for short-term administration in rheumatoid arthritis.
Marketing Status Prescription; Discontinued
ATC Code D07AA01; D10AA02; H02AB04
DrugBank ID DB14644
KEGG ID D05000
MeSH ID D008776
PubChem ID 16923
TTD Drug ID Not Available
NDC Product Code 57582-012; 24002-0015; 82298-109; 22552-0024; 52128-152
Synonyms Methylprednisolone Hemisuccinate | Hemisuccinate, Methylprednisolone | Methylprednisolone Succinate | Succinate, Methylprednisolone | Urbason-Soluble | UrbasonSoluble | Solu-Medrol | Solumedrol | A-MethaPred | Methylprednisolone Sodium Succinate | Sodium Succinate, Methylprednisolone | Methylprednisolone Hemisuccinate Monosodium Salt | 6 alpha-Methylprednisolone Sodium Hemisuccinate | Methylprednisolone Sodium Hemisuccinate | Sodium Hemisuccinate, Methylprednisolone
Chemical Information
Molecular Formula C26H34O8
CAS Registry Number 2921-57-5
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrial fibrillation02.03.03.0020.104919%
Atrophy08.03.04.001--Not Available
Autoimmune hepatitis10.04.09.001; 09.01.07.0190.048962%Not Available
Back pain15.03.04.0050.104919%
Bacteraemia11.01.11.0010.013989%
Benign intracranial hypertension17.07.02.001--Not Available
Blindness17.17.01.003; 06.02.02.001--Not Available
Blindness unilateral17.17.01.016; 06.02.02.0090.013989%Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Blood bilirubin increased13.03.01.0080.020984%
Blood creatinine increased13.13.01.004--
Blood glucose abnormal13.02.02.0080.041967%Not Available
Blood glucose increased13.02.02.0020.174864%Not Available
Blood immunoglobulin G increased13.06.05.0040.034973%Not Available
Blood potassium decreased13.11.01.0100.013989%Not Available
Blood pressure abnormal13.14.03.0010.041967%Not Available
Blood pressure decreased13.14.03.0020.104919%Not Available
Blood pressure fluctuation24.06.01.0020.013989%Not Available
Blood pressure increased13.14.03.0050.167870%Not Available
Blood urea increased13.13.01.006--Not Available
Body temperature increased13.15.01.0010.020984%Not Available
Bradycardia02.03.02.0020.090929%Not Available
Brain stem haemorrhage17.08.01.031; 24.07.04.0150.003649%Not Available
Bronchospasm10.01.03.012; 22.03.01.0040.118908%
Burning sensation17.02.06.001; 08.01.09.0290.055957%Not Available
C-reactive protein increased13.09.01.0070.034973%Not Available
Carbohydrate tolerance decreased13.02.02.003--Not Available
Cardiac arrest02.03.04.0010.021896%
Cardiac failure02.05.01.001--
Cardiac failure congestive02.05.01.002--Not Available
The 2th Page    First    Pre   2 3 4 5 6    Next   Last    Total 17 Pages